BMJ  2006;332:313-314 (11 February), doi:10.1136/bmj.332.7537.313

Editorial

The tobacco industry in developing countries

Has forestalled legislation on tobacco control

The first 150 words of the full text of this article appear below.

The multinational cigarette companies act as a vector that spreads disease and death throughout the world. This is largely because the tobacco industry uses its wealth to influence politicians to create a favourable environment to promote smoking. The industry does so by minimising restrictions on advertising and promotion and by preventing effective public policies for tobacco control such as high taxes,1 strong graphic warning labels on packets,2 w1 w2 smoke-free workplaces and public places,3 aggressive counter-marketing media campaigns,4 w3-w5 and advertising bans.1 Unlike mosquitoes, another vector of worldwide disease, the tobacco companies quickly transfer the information and strategies they learn in one part of the world to others.w6-w8

Responding to this global threat, as of January 2006, 121 countries had ratified the World Health Organization's Framework Convention on Tobacco Control (FCTC), the first global public health treaty. The details of how this treaty will be implemented are just beginning to emerge. Two . . . [Full text of this article]

Ernesto Sebrié, postdoctoral fellow

Center for Tobacco Control Research and Education, Cardiovascular Research Institute, Department of Medicine, University of California San Francisco, San Francisco, CA 94143-1390, USA
(ernesto.sebrie@ucsf.edu)

Stanton A Glantz, professor of medicine

Center for Tobacco Control Research and Education, Cardiovascular Research Institute, Department of Medicine, University of California San Francisco, San Francisco, CA 94143-1390, USA
(glantz@medicine.ucsf.edu)


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Articles

Who will lead WHO?
Anne Glusker
BMJ 2006 333: 938. [Extract] [Full Text] [PDF]

Mexico and the tobacco industry: Editorial lost sight of the real enemy
Mauricio Hernandez Avila
BMJ 2006 332: 548. [Extract] [Full Text] [PDF]

Mexico and the tobacco industry: Response from the Ministry of Health
Roberto Tapia-Conyer, Cristóbal Ruíz-Gaytán, and Luis Alfonso Caso-González
BMJ 2006 332: 548. [Extract] [Full Text]

A time for courage
Fiona Godlee
BMJ 2006 332: 0. [Extract] [Full Text] [PDF]

Mexico and the tobacco industry: doing the wrong thing for the right reason?
Jonathan Samet, Heather Wipfli, Rogelio Perez-Padilla, and Derek Yach
BMJ 2006 332: 353-354. [Full Text] [PDF]

British American Tobacco's erosion of health legislation in Uzbekistan
Anna B Gilmore, Jeff Collin, and Martin McKee
BMJ 2006 332: 355-358. [Full Text] [PDF]

Effect of smoke-free workplaces on smoking behaviour: systematic review
Caroline M Fichtenberg and Stanton A Glantz
BMJ 2002 325: 188. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • Glusker, A. (2006). Who will lead WHO?. BMJ 333: 938-938 [Full text]  
  • Avila, M. H. (2006). Mexico and the tobacco industry: editorial lost sight of the real enemy.. BMJ 332: 548-548 [Full text]  
  • Tapia-Conyer, R., Ruiz-Gaytan, C., Caso-Gonzalez, L. A. (2006). Mexico and the tobacco industry: response from the Ministry of Health.. BMJ 332: 548-548 [Full text]  

Rapid Responses:

Read all Rapid Responses

Tobacco control legislation has been challanged
Ediriweera Desapriya
bmj.com, 18 Feb 2006 [Full text]
Ban on smoking in UK
Ediriweera Desapriya
bmj.com, 18 Feb 2006 [Full text]
Losing Sight of the Real Enemy
Mauricio Hernandez Avila
bmj.com, 18 Feb 2006 [Full text]
Response of the Mexican MoH´s Officers to two BMJ editorials
Francisco J. López-Antuñano
bmj.com, 4 Mar 2006 [Full text]



Student BMJ

Intimate examinations

Israeli students are refusing to perform intimate examinations on anaesthetised women without their informed consent.

www.student.bmj.com

Listen to the latest BMJ Interview